Wilson Sonsini Goodrich & Rosati represented Boyu Capital in the transaction. The Longreach Group announced that it had, together with the founder family minority shareholders, completed...
Boyu Capital’s Acquisition of Quasar Medical
Oricell Therapeutics’ $45 Million Series B1 Financing
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
Wallaby Medical’s €500 Million Acquisition of Phenox
YPOG, Held Jaguttis, King & Spalding, KNPZ , Pusch Wahlig and Wilson Sonsini Goodrich & Rosati advised Wallaby Medical on the deal. Skadden, Arps, Slate, Meagher...
InSilico Medicine’s $255 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised InSilico Medicine on the deal. Ashurst represented Mirae Asset Capital. Hong Kong-based InSilico Medicine, a global leader in end-to-end artificial...